Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: A randomized controlled trial

European Journal of Clinical Pharmacology

Volumn 67, Issue 3, 2011, Pages 309-314

  Zhang, Qian ^a   Bal Dit Sollier, Claire ^a   Drouet, Ludovic ^a   Simoneau, Guy ^a   Alvarez, Jean Claude ^b   Pruvot, Sandrine ^a   Aubourg, Romain ^a   Berge, Natacha ^a   Bergmann, Jean Francois ^a   Mouly, Stéphane ^a   Mahé, Isabelle ^c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c HÔPITAL LOUIS MOURIER   (France)

Author keywords

Acetaminophen; Interaction; Mechanism; Warfarin

Indexed keywords

BLOOD CLOTTING FACTOR 8; PARACETAMOL; PLACEBO; PROTHROMBIN; WARFARIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG POTENTIATION; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MALE; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, NON-NARCOTIC; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; DRUG MONITORING; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; WARFARIN; YOUNG ADULT;

EID: 79954442559     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0975-2     Document Type: Article

References (18)

1. AM Holbrook JA Pereira R Labiris H McDonald JD Douketis M Crowther PS Wells 2005 Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 1095 1106 1:CAS:528:DC%2BD2MXlsFaju78%3D 10.1001/archinte.165.10.1095 15911722 (Pubitemid 40720733)
2. I Mahé N Bertrand L Drouet C Bal Dit Sollier G Simoneau E Mazoyer C Caulin JF Bergmann 2006 Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study Haematologica 91 1621 1627 17145598 (Pubitemid 46032959)
3. D Parra NP Beckey GR Stevens 2007 The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy Pharmacotherapy 27 675 683 1:CAS:528:DC%2BD2sXlvVKgu7k%3D 10.1592/phco.27.5.675 17461702 (Pubitemid 46700959)
4. MJ Toes AL Jones L Prescott 2005 Drug interactions with paracetamol Am J Ther 12 56 66 10.1097/00045391-200501000-00009 15662293 (Pubitemid 40516047)
5. MG Gebauer K Nyfort-Hansen PJ Henschke AS Gallus 2003 Warfarin and acetaminophen interaction Pharmacotherapy 23 109 112 10.1592/phco.23.1.109.31913 12523469 (Pubitemid 36077374)
6. IM Whyte NA Buckley DM Reith I Goodhew M Seldon AH Dawson 2000 Acetaminophen causes an increased International Normalized Ratio by reducing functional factor VII Ther Drug Monit 22 742 748 1:CAS:528:DC%2BD3cXovFGgs7w%3D 10.1097/00007691-200012000-00015 11128244
7. LF Prescott 2000 Therapeutic misadventure with paracetamol: fact or fiction? Am J Ther 7 99 114 1:STN:280:DC%2BD3MzitFKrsA%3D%3D 10.1097/00045391-200007020-00007 11319578
8. GP Aithal CP Day PJ Kesteven AK Daly 1999 Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications Lancet 353 717 719 1:STN:280:DyaK1M7ntFGhsQ%3D%3D 10.1016/S0140-6736(98)04474-2 10073515 (Pubitemid 29103806)
9. HH Thijssen BA Soute LM Vervoort JG Claessens 2004 Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle Thromb Haemost 92 797 802 1:CAS:528:DC%2BD2cXovVOlsbg%3D 15467911 (Pubitemid 39386707)
10. J Ansell 2008 Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 160S 198S 1:CAS:528:DC%2BD1cXptVKiu7o%3D 10.1378/chest.08-0670 18574265 (Pubitemid 351892967)
11. H Wada M Usui N Sakuragawa 2008 Hemostatic abnormalities and liver diseases Semin Thromb Hemost 34 772 778 1:CAS:528:DC%2BD1MXotFOitL0%3D 10.1055/s-0029-1145259 19214915
12. Zhang Q, Bal-dit-Sollier C, Drouet L, Simoneau G, Alvarez JC, Pruvot S, Aubourg R, Berge N, Bergmann JF, Mouly S, Mahé I (2010) Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial. Br J Clin Pharmacol, in press
13. JF Lassen J Kjeldsen S Antonsen P Hyltoft Petersen I Brandslund 1995 Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy Clin Chem 41 1171 1176 1:CAS:528:DyaK2MXnsV2itrc%3D 7628093
14. EM Hylek H Heiman SJ Skates MA Sheehan DE Singer 1998 Acetaminophen and other risk factors for excessive warfarin anticoagulation JAMA 279 657 662 1:CAS:528:DyaK1cXhvVyks7w%3D 10.1001/jama.279.9.657 9496982 (Pubitemid 28138733)
15. K Lown J Kolars K Turgeon R Merion SA Wrighton PB Watkins 1992 The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease Clin Pharmacol Ther 51 229 238 1:STN:280:DyaK387otlCitA%3D%3D 10.1038/clpt.1992.17 1544283
16. B Furie BA Bouchard BC Furie 1999 Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid Blood 93 1798 1808 1:CAS:528:DyaK1MXhvFSmt7Y%3D 10068650 (Pubitemid 29128479)
17. JD Fraser PA Price 1988 Lung, heart, and kidney express high levels of mRNA for the vitamin K-dependent matrix Gla protein. Implications for the possible functions of matrix Gla protein and for the tissue distribution of the gamma-carboxylase J Biol Chem 263 11033 11036 1:CAS:528:DyaL1cXltVyjtbw%3D 3042764
18. MH Knapen BS Hellemons-Boode M Langenberg-Ledeboer JA Knottnerus K Hamulyák PA Price C Vermeer 2000 Effect of oral anticoagulant treatment on markers for calcium and bone metabolism Haemostasis 30 290 297 1:CAS:528:DC%2BD3MXktlCksbs%3D 11356997 (Pubitemid 32453661)